<i>EPAS1</i> targeting by miR-152-3p in Paclitaxel-resistant Breast Cancer.

Song, Ying; Zhang, Mo; Lu, Man Man; Qu, Li Yuan; Xu, Si Guang; Li, Yong Zhen; Wang, Ming Yong; Zhu, Hui Fang; Zhang, Zhe Ying; He, Guo Yang; Yuan, Zhi Qing; Li, Na

EPAS1 targeting by miR-152-3p in Paclitaxel-resistant Breast Cancer.

Song, Ying; Zhang, Mo; Lu, Man Man; Qu, Li Yuan; Xu, Si Guang; Li, Yong Zhen; Wang, Ming Yong; Zhu, Hui Fang; Zhang, Zhe Ying; He, Guo Yang; Yuan, Zhi Qing; Li, Na.

Affiliation

Song Y; Department of Pathology, Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China.
Zhang M; Department of Physiology and Neurobiology, Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China.
Lu MM; Department of Pathology, Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China.
Qu LY; Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, P.R. China.
Xu SG; Department of Pathology, Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China.
Li YZ; Department of Pathology, Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China.
Wang MY; School of Laboratory Medicine, Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China.
Zhu HF; Xinxiang Key Laboratory of Immunoregulation and Molecular Diagnostics, Xinxiang, Henan 453003, P.R. China.
Zhang ZY; Department of Pathology, Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China.
He GY; Department of Pathology, Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China.
Yuan ZQ; Department of Pathology, Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China.
Li N; Department of Pathology, Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China.